Literature DB >> 23884140

Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.

Alaa S Awad1, Ting Gao, Anzor Gvritishvili, Hanning You, Yanling Liu, Timothy K Cooper, W Brian Reeves, Joyce Tombran-Tink.   

Abstract

Pigment epithelium-derived factor (PEDF) is a multifunctional protein with antiangiogenic, antioxidative, and anti-inflammatory properties. PEDF is involved in the pathogenesis of diabetic retinopathy, but its direct role in the kidneys remains unclear. We hypothesize that a PEDF fragment (P78-PEDF) confers kidney protection in diabetic nephropathy (DN). The localization of the full-length PEDF protein were determined in DBA mice following multiple low doses of streptozotocin. Using immunohistochemistry, PEDF was localized in the kidney vasculature, interstitial space, glomeruli, tubules, and renal medulla. Kidney PEDF protein and mRNA expression were significantly reduced in diabetic mice. Continuous infusion of P78-PEDF for 6 wk resulted in protection from diabetic neuropathy as indicated by reduced albuminuria and blood urea nitrogen, increased nephrin expression, decreased kidney macrophage recruitment and inflammatory cytokines, and reduced histological changes compared with vehicle-treated diabetic mice. In vitro, P78-PEDF blocked the increase in podocyte permeability to albumin and disruption of the actin cytoskeleton induced by puromycin aminonucleoside treatment. These findings highlight the importance of P78-PEDF peptide as a potential therapeutic modality in early phase diabetic renal injury.

Entities:  

Keywords:  diabetic nephropathy; pigment epithelium-derived factor; podocytes

Mesh:

Substances:

Year:  2013        PMID: 23884140      PMCID: PMC3761290          DOI: 10.1152/ajprenal.00149.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  39 in total

Review 1.  Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Authors:  Garabed Eknoyan; Thomas Hostetter; George L Bakris; Lee Hebert; Andrew S Levey; Hans-Henrik Parving; Michael W Steffes; Robert Toto
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 2.  Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential.

Authors:  Colin J Barnstable; Joyce Tombran-Tink
Journal:  Prog Retin Eye Res       Date:  2004-09       Impact factor: 21.198

3.  PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity.

Authors:  J Tombran-Tink; G G Chader; L V Johnson
Journal:  Exp Eye Res       Date:  1991-09       Impact factor: 3.467

4.  Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.

Authors:  M E Cooper; D Vranes; S Youssef; S A Stacker; A J Cox; B Rizkalla; D J Casley; L A Bach; D J Kelly; R E Gilbert
Journal:  Diabetes       Date:  1999-11       Impact factor: 9.461

5.  Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.

Authors:  Yanling Liu; Lan Franco Leo; Corban McGregor; Anzor Grivitishvili; Colin J Barnstable; Joyce Tombran-Tink
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

6.  Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis.

Authors:  T Nakamura; I Ebihara; M Fukui; S Osada; I Nagaoka; S Horikoshi; Y Tomino; H Koide
Journal:  Clin Immunol Immunopathol       Date:  1993-01

7.  Isolation, culture, and characterization of endothelial cells from mouse glomeruli.

Authors:  Nese Akis; Michael P Madaio
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

8.  Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

Authors:  Kambiz Kalantarinia; Alaa S Awad; Helmy M Siragy
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

9.  Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.

Authors:  Hua Liu; Jian-Guo Ren; William L Cooper; Charles E Hawkins; Mitra R Cowan; Patrick Y Tong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

10.  Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor.

Authors:  Joyce Tombran-Tink; Colin J Barnstable
Journal:  Trends Mol Med       Date:  2003-06       Impact factor: 11.951

View more
  11 in total

1.  Distinct roles of arginases 1 and 2 in diabetic nephropathy.

Authors:  Sidney M Morris; Hanning You; Ting Gao; Jean Vacher; Timothy K Cooper; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-26

2.  Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.

Authors:  Kelly J Hunt; Alicia J Jenkins; Dongxu Fu; Danielle Stevens; Jian-Xing Ma; Richard L Klein; Madona Azar; Sarah X Zhang; Maria F Lopes-Virella; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2019-07-26       Impact factor: 2.852

3.  Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.

Authors:  Hanning You; Ting Gao; Timothy K Cooper; Sidney M Morris; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-15

4.  Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.

Authors:  Michael D Wetzel; Ting Gao; Kristen Stanley; Timothy K Cooper; Sidney M Morris; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-06

Review 5.  PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases.

Authors:  Xuemin He; Rui Cheng; Siribhinya Benyajati; Jian-xing Ma
Journal:  Clin Sci (Lond)       Date:  2015-06       Impact factor: 6.124

6.  Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.

Authors:  Alaa S Awad; Hanning You; Ting Gao; Anzor Gvritishvili; Timothy K Cooper; Joyce Tombran-Tink
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.

Authors:  Ana Rubin; Anna C Salzberg; Yuka Imamura; Anzor Grivitishvilli; Joyce Tombran-Tink
Journal:  BMC Genomics       Date:  2016-11-17       Impact factor: 3.969

8.  Pigment Epithelium-Derived Factor Protects Retinal Neural Cells and Prevents Pathological Angiogenesis in an Ex Vivo Ischemia Model.

Authors:  Lei Xi; Marina Tikhonovich; Antje Biesemeier; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer; Alexander V Tschulakow
Journal:  Oxid Med Cell Longev       Date:  2022-08-05       Impact factor: 7.310

9.  Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes.

Authors:  Elaine Hui; Chun-Yip Yeung; Paul C H Lee; Yu-Cho Woo; Carol H Y Fong; Wing-Sun Chow; Aimin Xu; Karen S L Lam
Journal:  J Clin Endocrinol Metab       Date:  2014-08-28       Impact factor: 5.958

10.  Administration of Pigment Epithelium-Derived Factor Inhibits Airway Inflammation and Remodeling in Chronic OVA-Induced Mice via VEGF Suppression.

Authors:  Wangjian Zha; Mei Su; Mao Huang; Jiankang Cai; Qiang Du
Journal:  Allergy Asthma Immunol Res       Date:  2015-11-02       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.